Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S, La Pietra V, Piccarducci R, Pietrobono D, Cavallini C, D'Amore VM, Cerofolini L, Giuntini S, Russomanno P, Puxeddu M, Nalli M, Pedrini M, Fragai M, Luchinat C, Novellino E, Taliani S, La Regina G, Silvestri R, Martini C, Marinelli L. Daniele S, et al. Eur J Pharmacol. 2021 Apr 15;897:173936. doi: 10.1016/j.ejphar.2021.173936. Epub 2021 Feb 10. Eur J Pharmacol. 2021. PMID: 33581134
Adenosine receptors: what we know and what we are learning.
Trincavelli ML, Daniele S, Martini C. Trincavelli ML, et al. Among authors: daniele s. Curr Top Med Chem. 2010;10(9):860-77. doi: 10.2174/156802610791268756. Curr Top Med Chem. 2010. PMID: 20370662 Review.
Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation.
Taliani S, La Motta C, Mugnaini L, Simorini F, Salerno S, Marini AM, Da Settimo F, Cosconati S, Cosimelli B, Greco G, Limongelli V, Marinelli L, Novellino E, Ciampi O, Daniele S, Trincavelli ML, Martini C. Taliani S, et al. Among authors: daniele s. J Med Chem. 2010 May 27;53(10):3954-63. doi: 10.1021/jm901785w. J Med Chem. 2010. PMID: 20408530
Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motility.
Cosimelli B, Taliani S, Greco G, Novellino E, Sala A, Severi E, Da Settimo F, La Motta C, Pugliesi I, Antonioli L, Fornai M, Colucci R, Blandizzi C, Daniele S, Trincavelli ML, Martini C. Cosimelli B, et al. Among authors: daniele s. ChemMedChem. 2011 Oct 4;6(10):1909-18. doi: 10.1002/cmdc.201100284. Epub 2011 Jul 27. ChemMedChem. 2011. PMID: 21796795
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists.
Taliani S, Pugliesi I, Barresi E, Simorini F, Salerno S, La Motta C, Marini AM, Cosimelli B, Cosconati S, Di Maro S, Marinelli L, Daniele S, Trincavelli ML, Greco G, Novellino E, Martini C, Da Settimo F. Taliani S, et al. Among authors: daniele s. J Med Chem. 2012 Feb 23;55(4):1490-9. doi: 10.1021/jm201177b. Epub 2012 Feb 7. J Med Chem. 2012. PMID: 22257095
Modulation of PAR(1) signalling by benzimidazole compounds.
Asteriti S, Daniele S, Porchia F, Dell'Anno MT, Fazzini A, Pugliesi I, Trincavelli ML, Taliani S, Martini C, Mazzoni MR, Gilchrist A. Asteriti S, et al. Among authors: daniele s. Br J Pharmacol. 2012 Sep;167(1):80-94. doi: 10.1111/j.1476-5381.2012.01974.x. Br J Pharmacol. 2012. PMID: 22519452 Free PMC article.
3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.
Scatena A, Fornai F, Trincavelli ML, Taliani S, Daniele S, Pugliesi I, Cosconati S, Martini C, Da Settimo F. Scatena A, et al. Among authors: daniele s. ACS Chem Neurosci. 2011 Sep 21;2(9):526-35. doi: 10.1021/cn200036s. Epub 2011 Jun 10. ACS Chem Neurosci. 2011. PMID: 22860174 Free PMC article.
313 results